Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
about
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaGene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinomaProteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.A protein-based set of reference markers for liver tissues and hepatocellular carcinomaEnhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.Host proteome research in HIV infection.An overview of hepatocellular carcinoma study by omics-based methods.New tools for functional genomic analysis.Proteomics and liver fibrosis: identifying markers of fibrogenesis.Integrative oncoproteomics strategies for anticancer drug discovery.Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.Hepatic tight junctions: from viral entry to cancer metastasis.Biomarkers for hepatocellular carcinoma.
P2860
Q24595141-5C2B8D06-5D17-449B-91C7-AF133CA9ACBAQ28740309-A559A001-43F2-44AF-9944-2A5C474E631FQ33401908-2E93EF25-7323-4BD5-9457-667493713B13Q33441700-9089ACAF-5200-46A8-9E4C-77F127549B58Q33470083-341BAA96-7821-4700-9468-8A1273227B6EQ33499552-79F0988A-B806-49CB-949D-614E7D480B90Q33547822-0C08825E-5414-4BCB-871E-F4142C7AFBD6Q33961542-B5D6B44A-17DE-4F50-B312-005C96113262Q35479378-5208BB57-F0FF-4EE3-803B-60626D06EF78Q37235449-17199755-CDCD-43BA-8A62-6D4DDE90649CQ37318371-B0486282-F541-4D0C-B2D6-CBAB8D8E4B91Q37364456-C1753F6A-5DC7-4EDF-BCB2-BE1CC1FEC78FQ37499291-D6C7FDAB-B2A3-47D9-AB57-EF17C0499A5EQ37579910-C6C0A2E1-091F-4DF5-80D0-4EC47D7BEC58Q37763937-49948FF3-BEF8-4043-91A4-BA6E18A78D33Q37779804-6E69CC21-ED70-40DA-A3BE-572052661A64Q42935421-1A29DA17-7EB8-4688-806A-B048CF4DC9FFQ51595454-719060D7-444B-46AA-A625-2CE68DC607C1
P2860
Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@ast
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@en
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@nl
type
label
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@ast
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@en
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@nl
prefLabel
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@ast
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@en
Oncoproteomics of hepatocellul ...... covery to functional pathways.
@nl
P2093
P2860
P1433
P1476
Oncoproteomics of hepatocellul ...... scovery to functional pathways
@en
P2093
George K Lau
Nikki P Y Lee
Ronnie T P Poon
Sheung-Tat Fan
Stella Sun
P2860
P304
P356
10.1111/J.1478-3231.2007.01533.X
P577
2007-10-01T00:00:00Z